Ulcerative Colitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Ulcerative Colitis stocks.

Ulcerative Colitis Stocks Recent News

Date Stock Title
May 3 BHC Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
May 3 BHC Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
May 3 BHC Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
May 2 BHC Why Bausch Health Companies Stock Dived by More Than 7% Today
May 2 GLPG Galapagos reports Q1 results
May 2 VTYX Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
May 2 FBIO Mustang Bio Announces Closing of $4 Million Public Offering
May 2 GLPG Galapagos reports first quarter 2024 financial results
May 2 BHC Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript
May 2 BHC Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 BHC Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst ...
May 2 BHC Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates
May 2 BHC Bausch Health Companies GAAP EPS of -$0.17, revenue of $2.15B
May 2 BHC Bausch Health Announces First Quarter 2024 Results
May 1 GLPG Galapagos Q1 2024 Earnings Preview
May 1 FBIO Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
May 1 BHC Bausch Health Companies Q1 2024 Earnings Preview
May 1 BHC Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance
Apr 30 GLPG Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
Apr 30 VTYX What Makes Ventyx Biosciences (VTYX) a New Buy Stock
Ulcerative Colitis

Ulcerative colitis (UC) is a long-term condition that results in inflammation and ulcers of the colon and rectum. The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood. Weight loss, fever, and anemia may also occur. Often, symptoms come on slowly and can range from mild to severe. Symptoms typically occur intermittently with periods of no symptoms between flares. Complications may include megacolon, inflammation of the eye, joints, or liver, and colon cancer.The cause of UC is unknown. Theories involve immune system dysfunction, genetics, changes in the normal gut bacteria, and environmental factors. Rates tend to be higher in the developed world with some proposing this to be the result of less exposure to intestinal infections, or to a Western diet and lifestyle. The removal of the appendix at an early age may be protective. Diagnosis is typically by colonoscopy with tissue biopsies. It is a kind of inflammatory bowel disease (IBD) along with Crohn's disease and microscopic colitis.Dietary changes, such as maintaining a high-calorie diet or lactose-free diet, may improve symptoms. Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. Removal of the colon and rectum can cure the disease.Together with Crohn's disease, about 11.2 million people were affected as of 2015. Each year it newly occurs in 1 to 20 per 100,000 people, and 5 to 500 per 100,000 individuals are affected. The disease is more common in North America and Europe than other regions. Often it begins in people aged 15 to 30 years, or among those over 60. Males and females appear to be affected in equal proportions. It has also become more common since the 1950s. Together, ulcerative colitis and Crohn's disease affect about a million people in the United States. With appropriate treatment the risk of death appears the same as that of the general population. The first description of ulcerative colitis occurred around the 1850s.

Browse All Tags